Pharmacist-Driven Precision Medicine: A Ferry to Cross the Chasm of Interpreting Biomarker Testing Reports
- 1 August 2023
- journal article
- letter
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 19 (8) , 679-680
Abstract
Pharmacists as molecular oncology subspecialists can be integral to the multidisciplinary precision oncology team.Keywords
This publication has 6 references indexed in Scilit:
- Closing the Gap in Cancer Genomic TestingNew England Journal of Medicine, 2022
- Impact of Clinical Practice Gaps on the Implementation of Personalized Medicine in Advanced Non–Small-Cell Lung CancerJCO Precision Oncology, 2022
- Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical OpinionJournal of Clinical Oncology, 2022
- Precision pharmacotherapy: Integrating pharmacogenomics into clinical pharmacy practiceJACCP: Journal of the American College of Clinical Pharmacy, 2019
- Advancing pharmacy practice by reducing gaps in pharmacogenetic educationAmerican Journal of Health-System Pharmacy, 2019
- Key Lessons Learned from Moffitt’s Molecular Tumor Board: The Clinical Genomics Action Committee ExperienceThe Oncologist, 2017